Your browser doesn't support javascript.
loading
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.
von Minckwitz, G; Loibl, S; Untch, M; Eidtmann, H; Rezai, M; Fasching, P A; Tesch, H; Eggemann, H; Schrader, I; Kittel, K; Hanusch, C; Huober, J; Solbach, C; Jackisch, C; Kunz, G; Blohmer, J U; Hauschild, M; Fehm, T; Nekljudova, V; Gerber, B; Gnauert, K; Heinrich, B; Prätz, T; Groh, U; Tanzer, H; Villena, C; Tulusan, A; Liedtke, B; Blohmer, J-U; Kittel, K; Mau, C; Potenberg, J; Schilling, J; Just, M; Weiss, E; Bückner, U; Wolfgarten, M; Lorenz, R; Doering, G; Feidicker, S; Krabisch, P; Deichert, U; Augustin, D; Kunz, G; Kast, K; von Minckwitz, G; Nestle-Krämling, C; Rezai, M; Höß, C; Terhaag, J.
Affiliation
  • von Minckwitz G; Headquarter, German Breast Group, Neu-Isenburg; Department of Gynaecology and Obstetrics, University Hospital, Frankfurt. Electronic address: gunter.vonminckwitz@germanbreastgroup.de.
  • Loibl S; Headquarter, German Breast Group, Neu-Isenburg.
  • Untch M; Department of Gynaecology and Obstetrics, Klinikum Berlin-Buch, Berlin.
  • Eidtmann H; Department of Gynaecology and Obstetrics, University Hospital, Kiel.
  • Rezai M; Breast Center, Luisenkrankenhaus, Düsseldorf.
  • Fasching PA; Department of Gynaecology and Obstetrics, University Hospital, Erlangen.
  • Tesch H; Department of Medical Oncology, Chop GmbH, Frankfurt.
  • Eggemann H; Department of Gynaecology and Obstetrics, University Hospital, Magdeburg.
  • Schrader I; Department of Gynaecology and Obstetrics, Henriettenstiftung, Hannover.
  • Kittel K; Department of Gynaecology and Obstetrics, Praxisklinik, Berlin.
  • Hanusch C; Department of Gynaecology and Obstetrics, Rot-Kreuz-Klinikum, München.
  • Huober J; Department of Gynaecology and Obstetrics, University Hospital, Ulm.
  • Solbach C; Department of Gynaecology and Obstetrics, University Hospital, Frankfurt.
  • Jackisch C; Department of Gynaecology and Obstetrics, Sana-Klinikum, Offenbach.
  • Kunz G; Department of Gynaecology and Obstetrics, St Johannes Hospital, Dortmund.
  • Blohmer JU; Department of Gynaecology and Obstetrics, St Gertrauden-Hospital, Berlin.
  • Hauschild M; Department of Gynaecology and Obstetrics, Hospital, Rheinfelden.
  • Fehm T; Department of Gynaecology and Obstetrics, University Hospital, Tübingen.
  • Nekljudova V; Headquarter, German Breast Group, Neu-Isenburg.
  • Gerber B; Department of Gynaecology and Obstetrics, University Hospital, Rostock, Germany.
Ann Oncol ; 25(12): 2363-2372, 2014 Dec.
Article in En | MEDLINE | ID: mdl-25223482
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Sirolimus / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Adult / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Sirolimus / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Adult / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: Reino Unido